Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Evaluating the Safety and Efficacy of Transitioning Multiple Sclerosis Patients from Natalizumab to Rituximab
Multiple Sclerosis
(-)
187
Authors/Disclosures
James Stark, MD, FÂ鶹´«Ã½Ó³»­ (IMSMP)
PRESENTER 		Dr. Stark has nothing to disclose.
Armistead Williams III, MD (International MS Management Practice) Dr. Williams has nothing to disclose.
Saud Sadiq, BS, FÂ鶹´«Ã½Ó³»­ (Tisch Multiple Sclerosis Research Center of New York) Ms. Brewi has nothing to disclose.